However, RHOA mutation—another diffuse-type gastric cancer-related genomic variation [40], which was mutated in 3% of non-diffuse GC patients and in 9% of DGC patients, was not detected in any GLP patients in our cohort. The gene discussed is RHOA; the disease is gastric cancer.